{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:56:37Z","timestamp":1791600997552,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["272311"],"award-info":[{"award-number":["272311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00401-017-1786-7","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T05:38:59Z","timestamp":1510551539000},"page":"249-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease"],"prefix":"10.1007","volume":"135","author":[{"given":"Isabelle","family":"St-Amour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Goupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Planel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien S.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"1786_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","volume":"117","author":"T Arai","year":"2009","unstructured":"Arai T, Mackenzie IR, Hasegawa M et al (2009) Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 117:125\u2013136. \n                        https:\/\/doi.org\/10.1007\/s00401-008-0480-1","journal-title":"Acta Neuropathol"},{"key":"1786_CR2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0896-6273(95)90106-X","volume":"15","author":"N Aronin","year":"1995","unstructured":"Aronin N, Chase K, Young C et al (1995) CAG expansion affects the expression of mutant Huntingtin in the Huntington\u2019s disease brain. Neuron 15:1193\u20131201","journal-title":"Neuron"},{"key":"1786_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/hmg\/ddu421","volume":"24","author":"D Blum","year":"2015","unstructured":"Blum D, Herrera F, Francelle L et al (2015) Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet 24:76\u201385. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddu421","journal-title":"Hum Mol Genet"},{"key":"1786_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajmg.b.32514","volume":"174","author":"U Braisch","year":"2017","unstructured":"Braisch U, Hay B, Muche R et al (2017) Identification of extreme motor phenotypes in Huntington\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 174:283\u2013294. \n                        https:\/\/doi.org\/10.1002\/ajmg.b.32514","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1786_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, Bussi\u00e8re T, Bu\u00e9e-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Brain Res Rev"},{"key":"1786_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","volume":"10","author":"ML Caillet-Boudin","year":"2015","unstructured":"Caillet-Boudin ML, Bu\u00e9e L, Sergeant N, Lefebvre B (2015) Regulation of human MAPT gene expression. Mol Neurodegener 10:28. \n                        https:\/\/doi.org\/10.1186\/s13024-015-0025-8","journal-title":"Mol Neurodegener"},{"key":"1786_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01247-7","volume":"289","author":"V Charles","year":"2000","unstructured":"Charles V, Mezey E, Reddy PH et al (2000) Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington\u2019s disease patients and transgenic mouse models. Neurosci Lett 289:29\u201332","journal-title":"Neurosci Lett"},{"key":"1786_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1471-4159.2007.04857.x","volume":"103","author":"C Conrad","year":"2007","unstructured":"Conrad C, Zhu J, Conrad C et al (2007) Single molecule profiling of tau gene expression in Alzheimer\u2019s disease. J Neurochem 103:1228\u20131236. \n                        https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04857.x","journal-title":"J Neurochem"},{"key":"1786_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/hmg\/ddr477","volume":"21","author":"S Corrochano","year":"2012","unstructured":"Corrochano S, Renna M, Carter S et al (2012) \u03b1-Synuclein levels modulate Huntington\u2019s disease in mice. Hum Mol Genet 21:485\u2013494. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddr477","journal-title":"Hum Mol Genet"},{"key":"1786_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/elps.200900657","volume":"31","author":"M Cubillos-Rojas","year":"2010","unstructured":"Cubillos-Rojas M, Amair-Pinedo F, Tato I et al (2010) Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels. Electrophoresis 31:1318\u20131321. \n                        https:\/\/doi.org\/10.1002\/elps.200900657","journal-title":"Electrophoresis"},{"key":"1786_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JHD-140111","volume":"3","author":"MY Davis","year":"2014","unstructured":"Davis MY, Keene CD, Jayadev S et al (2014) The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: a neuropathological study of 15 elderly Huntington\u2019s disease subjects. J Huntingtons Dis 3:209\u2013217. \n                        https:\/\/doi.org\/10.3233\/JHD-140111","journal-title":"J Huntingtons Dis"},{"key":"1786_CR12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"1786_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1017\/S1355617716000928","volume":"22","author":"EC Edmonds","year":"2016","unstructured":"Edmonds EC, Bangen KJ, Delano-Wood L et al (2016) Patterns of cortical and subcortical amyloid burden across stages of preclinical Alzheimer\u2019s disease. J Int Neuropsychol Soc 22:978\u2013990. \n                        https:\/\/doi.org\/10.1017\/S1355617716000928","journal-title":"J Int Neuropsychol Soc"},{"key":"1786_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jnen\/nlw002","volume":"75","author":"A Elobeid","year":"2016","unstructured":"Elobeid A, Libard S, Leino M et al (2016) Altered proteins in the aging brain. J Neuropathol Exp Neurol 75:316\u2013325. \n                        https:\/\/doi.org\/10.1093\/jnen\/nlw002","journal-title":"J Neuropathol Exp Neurol"},{"key":"1786_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fernandez-Nogales","year":"2014","unstructured":"Fernandez-Nogales M, Cabrera JR, Santos-Galindo M et al (2014) Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881\u2013885. \n                        https:\/\/doi.org\/10.1038\/nm.3617","journal-title":"Nat Med"},{"key":"1786_CR16","doi-asserted-by":"publisher","first-page":"938530","DOI":"10.1155\/2014\/938530","volume":"2014","author":"C Fourie","year":"2014","unstructured":"Fourie C, Kim E, Waldvogel H et al (2014) Differential changes in postsynaptic density proteins in postmortem Huntington\u2019s disease and Parkinson\u2019s disease human brains. J Neurodegener Dis 2014:938530. \n                        https:\/\/doi.org\/10.1155\/2014\/938530","journal-title":"J Neurodegener Dis"},{"key":"1786_CR17","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1172\/JCI66029","volume":"123","author":"TE Golde","year":"2013","unstructured":"Golde TE, Borchelt DR, Giasson BI et al (2013) Thinking laterally about neurodegenerative proteinopathies. J Clin Invest 123:1847\u20131855. \n                        https:\/\/doi.org\/10.1172\/JCI66029","journal-title":"J Clin Invest"},{"key":"1786_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/brain\/aww021","volume":"139","author":"M Gratuze","year":"2016","unstructured":"Gratuze M, Cisbani G, Cicchetti F et al (2016) Is Huntington\u2019s disease a tauopathy. Brain 139:1014\u20131025. \n                        https:\/\/doi.org\/10.1093\/brain\/aww021","journal-title":"Brain"},{"key":"1786_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/hmg\/ddu456","volume":"24","author":"M Gratuze","year":"2015","unstructured":"Gratuze M, No\u00ebl A, Julien C et al (2015) Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease. Hum Mol Genet 24:86\u201399. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddu456","journal-title":"Hum Mol Genet"},{"key":"1786_CR20","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1073\/pnas.87.15.5827","volume":"87","author":"SG Greenberg","year":"1990","unstructured":"Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87:5827\u20135831","journal-title":"Proc Natl Acad Sci USA"},{"key":"1786_CR21","doi-asserted-by":"publisher","first-page":"44849","DOI":"10.1038\/srep44849","volume":"7","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss DJ, Flower MD, Lo KK et al (2017) Huntington\u2019s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer\u2019s disease. Sci Rep 7:44849. \n                        https:\/\/doi.org\/10.1038\/srep44849","journal-title":"Sci Rep"},{"key":"1786_CR22","doi-asserted-by":"publisher","first-page":"30953","DOI":"10.1038\/srep30953","volume":"6","author":"J Hernandez-Rapp","year":"2016","unstructured":"Hernandez-Rapp J, Rainone S, Goupil C et al (2016) microRNA-132\/212 deficiency enhances A\u03b2 production and senile plaque deposition in Alzheimer\u2019s disease triple transgenic mice. Sci Rep 6:30953. \n                        https:\/\/doi.org\/10.1038\/srep30953","journal-title":"Sci Rep"},{"key":"1786_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK et al (2006) Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 15:965\u2013977. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddl013","journal-title":"Hum Mol Genet"},{"key":"1786_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/brainsci4010091","volume":"4","author":"G Hoffner","year":"2014","unstructured":"Hoffner G, Djian P (2014) Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion. Brain Sci 4:91\u2013122. \n                        https:\/\/doi.org\/10.3390\/brainsci4010091","journal-title":"Brain Sci"},{"key":"1786_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1471-4159.2005.03348.x","volume":"95","author":"G Hoffner","year":"2005","unstructured":"Hoffner G, Island ML, Djian P (2005) Purification of neuronal inclusions of patients with Huntington\u2019s disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers. J Neurochem 95:125\u2013136. \n                        https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03348.x","journal-title":"J Neurochem"},{"key":"1786_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41598-017-01587-6","volume":"7","author":"M Hosokawa","year":"2017","unstructured":"Hosokawa M, Kondo H, Serrano GE et al (2017) Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation. Sci Rep 7:1513. \n                        https:\/\/doi.org\/10.1038\/s41598-017-01587-6","journal-title":"Sci Rep"},{"key":"1786_CR27","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00415-016-8233-x","volume":"263","author":"M Jacobs","year":"2016","unstructured":"Jacobs M, Hart EP, van Zwet EW et al (2016) Progression of motor subtypes in Huntington\u2019s disease: a 6-year follow-up study. J Neurol 263:2080\u20132085. \n                        https:\/\/doi.org\/10.1007\/s00415-016-8233-x","journal-title":"J Neurol"},{"key":"1786_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s007020050095","volume":"105","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Alzheimer-type lesions in Huntington\u2019s disease. J Neural Transm (Vienna) 105:787\u2013799. \n                        https:\/\/doi.org\/10.1007\/s007020050095","journal-title":"J Neural Transm (Vienna)"},{"key":"1786_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00702-014-1288-x","volume":"122","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA, Attems J (2015) Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) 122:505\u2013521. \n                        https:\/\/doi.org\/10.1007\/s00702-014-1288-x","journal-title":"J Neural Transm (Vienna)"},{"key":"1786_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.24493","volume":"78","author":"KA Josephs","year":"2015","unstructured":"Josephs KA, Whitwell JL, Tosakulwong N et al (2015) TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features. Ann Neurol 78:697\u2013709. \n                        https:\/\/doi.org\/10.1002\/ana.24493","journal-title":"Ann Neurol"},{"key":"1786_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/978-1-61779-551-0_32","volume":"849","author":"C Julien","year":"2012","unstructured":"Julien C, Bretteville A, Planel E (2012) Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Methods Mol Biol 849:473\u2013491. \n                        https:\/\/doi.org\/10.1007\/978-1-61779-551-0_32","journal-title":"Methods Mol Biol"},{"key":"1786_CR32","doi-asserted-by":"publisher","first-page":"23281","DOI":"10.1038\/srep23281","volume":"6","author":"F Kametani","year":"2016","unstructured":"Kametani F, Obi T, Shishido T et al (2016) Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep 6:23281. \n                        https:\/\/doi.org\/10.1038\/srep23281","journal-title":"Sci Rep"},{"key":"1786_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/mds.21937","volume":"23","author":"K Kanai","year":"2008","unstructured":"Kanai K, Kuwabara S, Sawai S et al (2008) Genetically confirmed Huntington\u2019s disease masquerading as motor neuron disease. Mov Disord 23:748\u2013751. \n                        https:\/\/doi.org\/10.1002\/mds.21937","journal-title":"Mov Disord"},{"key":"1786_CR34","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ebiom.2015.08.002","volume":"2","author":"S Kloppel","year":"2015","unstructured":"Kloppel S, Gregory S, Scheller E et al (2015) Compensation in preclinical Huntington\u2019s disease: evidence from the track-on HD study. EBioMedicine 2:1420\u20131429. \n                        https:\/\/doi.org\/10.1016\/j.ebiom.2015.08.002","journal-title":"EBioMedicine"},{"key":"1786_CR35","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/mds.22697","volume":"24","author":"GG Kovacs","year":"2009","unstructured":"Kovacs GG, Murrell JR, Horvath S et al (2009) TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24:1843\u20131847. \n                        https:\/\/doi.org\/10.1002\/mds.22697","journal-title":"Mov Disord"},{"key":"1786_CR36","doi-asserted-by":"publisher","first-page":"e2206","DOI":"10.1038\/cddis.2016.104","volume":"7","author":"F L\u2019Episcopo","year":"2016","unstructured":"L\u2019Episcopo F, Drouin-Ouellet J, Tirolo C et al (2016) GSK-3\u03b2-induced Tau pathology drives hippocampal neuronal cell death in Huntington\u2019s disease: involvement of astrocyte\u2013neuron interactions. Cell Death Dis 7:e2206. \n                        https:\/\/doi.org\/10.1038\/cddis.2016.104","journal-title":"Cell Death Dis"},{"key":"1786_CR37","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V et al (2015) RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One 10:e0143563. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0143563","journal-title":"PLoS One"},{"key":"1786_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ana.410370213","volume":"37","author":"GB Landwehrmeyer","year":"1995","unstructured":"Landwehrmeyer GB, McNeil SM, Dure LS et al (1995) Huntington\u2019s disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218\u2013230. \n                        https:\/\/doi.org\/10.1002\/ana.410370213","journal-title":"Ann Neurol"},{"key":"1786_CR39","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","volume":"32","author":"ME Larson","year":"2012","unstructured":"Larson ME, Sherman MA, Greimel S et al (2012) Soluble \u03b1-synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology. J Neurosci 32:10253\u201310266. \n                        https:\/\/doi.org\/10.1523\/JNEUROSCI.0581-12.2012","journal-title":"J Neurosci"},{"key":"1786_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","volume":"27","author":"J Lautenschlager","year":"2017","unstructured":"Lautenschlager J, Kaminski CF, Kaminski Schierle GS (2017) \u03b1-Synuclein\u2014regulator of exocytosis, endocytosis, or both. Trends Cell Biol 27:468\u2013479. \n                        https:\/\/doi.org\/10.1016\/j.tcb.2017.02.002","journal-title":"Trends Cell Biol"},{"key":"1786_CR41","doi-asserted-by":"publisher","first-page":"e84849","DOI":"10.1371\/journal.pone.0084849","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, G\u00f6tz J (2013) Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS One 8:e84849. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0084849","journal-title":"PLoS One"},{"key":"1786_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuropsychologia.2015.02.017","volume":"70","author":"SL Mason","year":"2015","unstructured":"Mason SL, Zhang J, Begeti F et al (2015) The role of the amygdala during emotional processing in Huntington\u2019s disease: from pre-manifest to late stage disease. Neuropsychologia 70:80\u201389. \n                        https:\/\/doi.org\/10.1016\/j.neuropsychologia.2015.02.017","journal-title":"Neuropsychologia"},{"key":"1786_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/PREACCEPT-1296467154135944","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M et al (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88. \n                        https:\/\/doi.org\/10.1186\/PREACCEPT-1296467154135944","journal-title":"Acta Neuropathol Commun"},{"key":"1786_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2016.08.015","volume":"96","author":"NF Mehrabi","year":"2016","unstructured":"Mehrabi NF, Waldvogel HJ, Tippett LJ et al (2016) Symptom heterogeneity in Huntington\u2019s disease correlates with neuronal degeneration in the cerebral cortex. Neurobiol Dis 96:67\u201374. \n                        https:\/\/doi.org\/10.1016\/j.nbd.2016.08.015","journal-title":"Neurobiol Dis"},{"key":"1786_CR45","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/hmg\/ddw142","volume":"25","author":"JR Miller","year":"2016","unstructured":"Miller JR, Lo KK, Andre R et al (2016) RNA-Seq of Huntington\u2019s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation. Hum Mol Genet 25:2893\u20132904. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddw142","journal-title":"Hum Mol Genet"},{"key":"1786_CR46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005072-199804000-00007","volume":"57","author":"J Nakabayashi","year":"1998","unstructured":"Nakabayashi J, Yoshimura M, Morishima-Kawashima M et al (1998) Amyloid beta-protein (A beta) accumulation in the putamen and mammillary body during aging and in Alzheimer disease. J Neuropathol Exp Neurol 57:343\u2013352","journal-title":"J Neuropathol Exp Neurol"},{"key":"1786_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1042\/BST20120091","volume":"40","author":"M Niblock","year":"2012","unstructured":"Niblock M, Gallo JM (2012) Tau alternative splicing in familial and sporadic tauopathies. Biochem Soc Trans 40:677\u2013680. \n                        https:\/\/doi.org\/10.1042\/BST20120091","journal-title":"Biochem Soc Trans"},{"key":"1786_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1371\/currents.RRN1184","volume":"2","author":"M Orth","year":"2010","unstructured":"Orth M, Handley OJ, Schwenke C et al (2010) Observing Huntington\u2019s disease: the European Huntington\u2019s disease network\u2019s REGISTRY. PLoS Curr 2:184. \n                        https:\/\/doi.org\/10.1371\/currents.RRN1184","journal-title":"PLoS Curr"},{"key":"1786_CR49","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00415-006-0267-z","volume":"253","author":"SG Papageorgiou","year":"2006","unstructured":"Papageorgiou SG, Antelli A, Bonakis A et al (2006) Association of genetically proven Huntington\u2019s disease and sporadic amyotrophic lateral sclerosis in a 72-year-old woman. J Neurol 253:1649\u20131650. \n                        https:\/\/doi.org\/10.1007\/s00415-006-0267-z","journal-title":"J Neurol"},{"key":"1786_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mds.25864","volume":"29","author":"M Papoutsi","year":"2014","unstructured":"Papoutsi M, Labuschagne I, Tabrizi SJ et al (2014) The cognitive burden in Huntington\u2019s disease: pathology, phenotype, and mechanisms of compensation. Mov Disord 29:673\u2013683. \n                        https:\/\/doi.org\/10.1002\/mds.25864","journal-title":"Mov Disord"},{"key":"1786_CR51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5483\/BMBRep.2016.49.8.084","volume":"49","author":"SA Park","year":"2016","unstructured":"Park SA, Ahn SI, Gallo JM (2016) Tau mis-splicing in the pathogenesis of neurodegenerative disorders. BMB Rep 49:405\u2013413","journal-title":"BMB Rep"},{"key":"1786_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney JB, Vonsattel JP, MacDonald ME et al (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41:689\u2013692. \n                        https:\/\/doi.org\/10.1002\/ana.410410521","journal-title":"Ann Neurol"},{"key":"1786_CR53","doi-asserted-by":"publisher","first-page":"e94251","DOI":"10.1371\/journal.pone.0094251","volume":"9","author":"FR Petry","year":"2014","unstructured":"Petry FR, Pelletier J, Bretteville A et al (2014) Specificity of anti-tau antibodies when analyzing mice models of Alzheimer\u2019s disease: problems and solutions. PLoS One 9:e94251. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0094251","journal-title":"PLoS One"},{"key":"1786_CR54","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/hmg\/ddu606","volume":"24","author":"GM Po\u00e7as","year":"2015","unstructured":"Po\u00e7as GM, Branco-Santos J, Herrera F et al (2015) \u03b1-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila. Hum Mol Genet 24:1898\u20131907. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddu606","journal-title":"Hum Mol Genet"},{"key":"1786_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2407-9-90","volume":"9","author":"FE Rosa","year":"2009","unstructured":"Rosa FE, Silveira SM, Silveira CG et al (2009) Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma. BMC Cancer 9:90. \n                        https:\/\/doi.org\/10.1186\/1471-2407-9-90","journal-title":"BMC Cancer"},{"key":"1786_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1427.034","volume":"1147","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY et al (2008) Complexity and heterogeneity: what drives the ever-changing brain in Huntington\u2019s disease. Ann N Y Acad Sci 1147:196\u2013205. \n                        https:\/\/doi.org\/10.1196\/annals.1427.034","journal-title":"Ann N Y Acad Sci"},{"key":"1786_CR57","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mds.24024","volume":"27","author":"A Rosenblatt","year":"2012","unstructured":"Rosenblatt A, Kumar BV, Mo A et al (2012) Age, CAG repeat length, and clinical progression in Huntington\u2019s disease. Mov Disord 27:272\u2013276. \n                        https:\/\/doi.org\/10.1002\/mds.24024","journal-title":"Mov Disord"},{"key":"1786_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"1786_CR59","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U R\u00fcb","year":"2016","unstructured":"R\u00fcb U, Seidel K, Heinsen H et al (2016) Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol 26:726\u2013740. \n                        https:\/\/doi.org\/10.1111\/bpa.12426","journal-title":"Brain Pathol"},{"key":"1786_CR60","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/archneurol.2011.76","volume":"68","author":"H Sadeghian","year":"2011","unstructured":"Sadeghian H, O\u2019Suilleabhain PE, Battiste J et al (2011) Huntington chorea presenting with motor neuron disease. Arch Neurol 68:650\u2013652. \n                        https:\/\/doi.org\/10.1001\/archneurol.2011.76","journal-title":"Arch Neurol"},{"key":"1786_CR61","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/hmg\/4.8.1365","volume":"4","author":"G Schilling","year":"1995","unstructured":"Schilling G, Sharp AH, Loev SJ et al (1995) Expression of the Huntington\u2019s disease (IT15) protein product in HD patients. Hum Mol Genet 4:1365\u20131371","journal-title":"Hum Mol Genet"},{"key":"1786_CR62","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M et al (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67:1159\u20131165. \n                        https:\/\/doi.org\/10.1097\/NEN.0b013e31818e8951","journal-title":"J Neuropathol Exp Neurol"},{"key":"1786_CR63","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/exnr.1998.7005","volume":"156","author":"KA Sieradzan","year":"1999","unstructured":"Sieradzan KA, Mechan AO, Jones L et al (1999) Huntington\u2019s disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 156:92\u201399. \n                        https:\/\/doi.org\/10.1006\/exnr.1998.7005","journal-title":"Exp Neurol"},{"key":"1786_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1471-4159.2007.04703.x","volume":"103","author":"R Smith","year":"2007","unstructured":"Smith R, Klein P, Koc-Schmitz Y et al (2007) Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington\u2019s disease. J Neurochem 103:115\u2013123. \n                        https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04703.x","journal-title":"J Neurochem"},{"key":"1786_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205. \n                        https:\/\/doi.org\/10.1007\/s00401-017-1709-7","journal-title":"Acta Neuropathol"},{"key":"1786_CR66","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(09)70170-X","journal-title":"Lancet Neurol"},{"key":"1786_CR67","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","volume":"124","author":"M Tada","year":"2012","unstructured":"Tada M, Coon EA, Osmand AP et al (2012) Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 124:749\u2013760. \n                        https:\/\/doi.org\/10.1007\/s00401-012-1005-5","journal-title":"Acta Neuropathol"},{"key":"1786_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-016-0335-2","volume":"4","author":"R Takeuchi","year":"2016","unstructured":"Takeuchi R, Tada M, Shiga A et al (2016) Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: evidence for clinico-pathologic subtypes. Acta Neuropathol Commun 4:61. \n                        https:\/\/doi.org\/10.1186\/s40478-016-0335-2","journal-title":"Acta Neuropathol Commun"},{"key":"1786_CR69","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"1786_CR70","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/hmg\/ddr507","volume":"21","author":"C Tomas-Zapico","year":"2012","unstructured":"Tomas-Zapico C, D\u00edez-Zaera M, Ferrer I et al (2012) \u03b1-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington\u2019s disease. Hum Mol Genet 21:495\u2013510. \n                        https:\/\/doi.org\/10.1093\/hmg\/ddr507","journal-title":"Hum Mol Genet"},{"key":"1786_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlw109","author":"C Tremblay","year":"2017","unstructured":"Tremblay C, Fran\u00e7ois A, Delay C et al (2017) Association of neuropathological markers in the parietal cortex with antemortem cognitive function in persons with mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. \n                        https:\/\/doi.org\/10.1093\/jnen\/nlw109","journal-title":"J Neuropathol Exp Neurol"},{"key":"1786_CR72","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","volume":"70","author":"C Tremblay","year":"2011","unstructured":"Tremblay C, St-Amour I, Schneider J et al (2011) Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 70:788\u2013798. \n                        https:\/\/doi.org\/10.1097\/NEN.0b013e31822c62cf","journal-title":"J Neuropathol Exp Neurol"},{"key":"1786_CR73","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1373\/clinchem.2004.044305","volume":"51","author":"C Tse","year":"2005","unstructured":"Tse C, Brault D, Gligorov J et al (2005) Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients. Clin Chem 51:1093\u20131101. \n                        https:\/\/doi.org\/10.1373\/clinchem.2004.044305","journal-title":"Clin Chem"},{"key":"1786_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino A, Takao M, Hatsuta H et al (2015) Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol Commun 3:35. \n                        https:\/\/doi.org\/10.1186\/s40478-015-0215-1","journal-title":"Acta Neuropathol Commun"},{"key":"1786_CR75","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awv107","volume":"138","author":"R Vuono","year":"2015","unstructured":"Vuono R, Winder-Rhodes S, de Silva R et al (2015) The role of tau in the pathological process and clinical expression of Huntington\u2019s disease. Brain 138:1907\u20131918. \n                        https:\/\/doi.org\/10.1093\/brain\/awv107","journal-title":"Brain"},{"key":"1786_CR76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-5434-2_9","volume":"769","author":"HJ Waldvogel","year":"2012","unstructured":"Waldvogel HJ, Thu D, Hogg V et al (2012) Selective neurodegeneration, neuropathology and symptom profiles in Huntington\u2019s disease. Adv Exp Med Biol 769:141\u2013152","journal-title":"Adv Exp Med Biol"},{"key":"1786_CR77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.60.1.78","volume":"60","author":"JH Xuereb","year":"1996","unstructured":"Xuereb JH, MacMillan JC, Snell R et al (1996) Neuropathological diagnosis and CAG repeat expansion in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 60:78\u201381","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1786_CR78","doi-asserted-by":"publisher","first-page":"30497","DOI":"10.1074\/jbc.M112.355412","volume":"287","author":"X Yin","year":"2012","unstructured":"Yin X, Jin N, Gu J et al (2012) Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine\/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion. J Biol Chem 287:30497\u201330506. \n                        https:\/\/doi.org\/10.1074\/jbc.M112.355412","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1786-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T06:50:48Z","timestamp":1516258248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1786-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1786"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1786-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]}}}